《医学技术证券通讯》（Medical Technology Stock Letter）编辑John McCaman表示，Mott的离职是两家公司合并过程中的又一个逻辑转换，Mott是一名CEO，而非顶尖科学家，因此Mott并不是阿斯利...
基于1个网页-相关网页
medical technology stock letter
医疗技术股票信
以上为机器翻译结果，长、整句建议使用 人工翻译 。
Click here for more biotechnology stock analysis and recommendations from John McCamant in Medical Technology Stock Letter.
FORBES: Biotech Pipeline Play
John McCamant, editor of the Medical Technology Stock Letter, urges his readers not to bail on biotech.
FORBES: Magazine Article
Overvaluation is also a theme with John McCamant, co-editor of the Medical Technology Stock Letter in Berkeley, Calif.
FORBES: Beware Of Biotechs At Cancer-Cure Prices
应用推荐
模块上移
模块下移
不移动